BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24336323)

  • 1. TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state.
    Mori T; Sato Y; Miyamoto K; Kobayashi T; Shimizu T; Kanagawa H; Katsuyama E; Fujie A; Hao W; Tando T; Iwasaki R; Kawana H; Morioka H; Matsumoto M; Saya H; Toyama Y; Miyamoto T
    Oncogene; 2014 Aug; 33(33):4236-41. PubMed ID: 24336323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-17-IL-17RA axis is required to promote osteosarcoma progression in mice.
    Yoshimura N; Kariya R; Shimada M; Tateyama M; Matsunaga H; Shibata Y; Tanimura S; Takata K; Arima T; Kawakami J; Maeda K; Fukuma Y; Uragami M; Ideo K; Sugimoto K; Yonemitsu R; Matsushita K; Hisanaga S; Yugami M; Uehara Y; Masuda T; Nakamura T; Tokunaga T; Karasugi T; Sueyoshi T; Sato H; Iwakura Y; Araki K; Kobayashi E; Okada S; Miyamoto T
    Sci Rep; 2023 Dec; 13(1):21572. PubMed ID: 38062130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
    Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
    Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells.
    Wang L; Wang Y; Sato T; Yamagata S; Yamagata T
    Biochem Biophys Res Commun; 2008 Jun; 371(2):230-5. PubMed ID: 18435913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
    Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
    Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin-6/soluble interleukin-6 receptor system induces parathyroid hormone-related protein in human osteoblastic cells.
    Guillén C; de Gortázar AR; Esbrit P
    Calcif Tissue Int; 2004 Aug; 75(2):153-9. PubMed ID: 15129368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
    Haydon RC; Luu HH; He TC
    Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle.
    McDonald AC; Schuijers JA; Gundlach AL; Grills BL
    Bone; 2007 Apr; 40(4):895-903. PubMed ID: 17157570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
    Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
    Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.
    Baker EK; Taylor S; Gupte A; Chalk AM; Bhattacharya S; Green AC; Martin TJ; Strbenac D; Robinson MD; Purton LE; Walkley CR
    Bone; 2015 Apr; 73():223-32. PubMed ID: 25571841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of Tnfalpha demonstrates no detectable suppressive effect on inflammation-related mouse colon tumorigenesis.
    Sakai H; Yamada Y; Shimizu M; Saito K; Moriwaki H; Hara A
    Chem Biol Interact; 2010 Mar; 184(3):423-30. PubMed ID: 20079348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
    Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
    Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
    Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
    Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROCK Inhibition Induces Terminal Adipocyte Differentiation and Suppresses Tumorigenesis in Chemoresistant Osteosarcoma Cells.
    Takahashi N; Nobusue H; Shimizu T; Sugihara E; Yamaguchi-Iwai S; Onishi N; Kunitomi H; Kuroda T; Saya H
    Cancer Res; 2019 Jun; 79(12):3088-3099. PubMed ID: 30992323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.